Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4f-benzoyl-TN14003

Stem Cells

Volumn 25, Issue 9, 2007, Pages 2158-2166

  Abraham, Michal ^a   Biyder, Katia ^a   Begin, Michal ^a   Wald, Hanna ^a   Weiss, Ido D ^a   Galun, Eithan ^a   Nagler, Arnon ^b   Peled, Amnon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

CXCR4; Hematopoietic progenitors; Hematopoietic stem cells; Mobilization

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1; T 140;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; ERYTHROBLAST; FEMALE; HEMATOPOIETIC CELL; LEUKOCYTE; MOUSE; NONHUMAN; PROTEIN INTERACTION; STEM CELL MOBILIZATION;

ANIMALS; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; LEUKOCYTES; MICE; MICE, INBRED C57BL; PEPTIDES; RECEPTORS, CXCR4;

EID: 34748870155     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0161     Document Type: Article

References (37)

1. Kondo M, Wagers AJ, Manz MG et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 2003;21:759-806.
2. Wright DE, Wagers AJ, Gulati AP et al. Physiological migration of hematopoietic stem and progenitor cells. Science 2001;294:1933-1936.
3. Abkowitz JL, Robinson AE, Kale S et al. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 2003;102:1249-1253.
4. Roberts AW, DeLuca E, Begley CG et al. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. STEM CELLS 1995;13:512-516.
5. Kollet O, Petit I, Kahn J et al. Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. Blood 2002;100:2778-2786.
6. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002;16:1992-2003.
7. Levesque JP, Hendy J, Takamatsu Y et al. Disruption of the CXCR4/ CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;111:187-196.
8. Kim CH, Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: Stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 1998;91:100-110.
9. Broxmeyer HE, Orschell CM, Clapp DW et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005;201:1307-1318.
10. Princen K, Schols D. HIV chemokine receptor inhibitors as novel anti-HIV drugs. Cytokine Growth Factor Rev 2005;16:659-677.
11. Tamamura H, Fujii N. The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis. Expert Opin Ther Targets 2005;9:1267-1282.
12. Juarez J, Bradstock KF, Gottlieb DJ et al. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia 2003;17:1294-1300.
13. Leenen PJ, de Bruijn MF, Voerman JS et al. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 1994;174:5-19.
14. Flomenberg N, Devine SM, Dipersio JF et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005;106:1867-1874.
15. Flomenberg N, DiPersio J, Calandra G. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells. Acta Haematol 2005;114:198 -205.
16. Liles WC, Broxmeyer HE, Rodger E et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003;102:2728-2730.
17. Hartmann O, Le Corroller AG, Blaise D et al. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: Hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 1997;126:600-607.
18. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996;347:353-357.
19. Beyer J, Schwella N, Zingsem J et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. J Clin Oncol 1995;13:1328-1335.
20. Zarco MA, Ribera JM, Urbano-Ispizua A et al. Phenotypic changes in neutrophil granulocytes of healthy donors after G-CSF administration. Haematologica 1999;84:874-878.
21. Dale DC. Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs 2002;62(suppl 1):1-15.
22. Bedell C. Pegfilgrastim for chemotherapy-induced neutropenia. Clin J Oncol Nurs 2003;7:55-56, 63-64.
23. Glaspy JA, Shpall EJ, LeMaistre CF et al. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood 1997;90:2939-2951.
24. Huhn RD, Yurkow EJ, Tushinski R et al. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhGCSF) in normal volunteers. Exp Hematol 1996;24:839-847.
25. Molineux G, McCrea C, Yan XQ et al. Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood 1997;89:3998-4004.
26. Petit I, Szyper-Kravitz M, Nagler A et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-694.
27. Hendrix CW, Collier AC, Lederman MM et al. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 2004;37:1253-1262.
28. Burroughs L, Mielcarek M, Little MT et al. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model. Blood 2005;106:4002-4008.
29. Larochelle A, Krouse A, Metzger M et al. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood 2006;107:3772-3778.
30. Devine SM, Flomenberg N, Vesole DH et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol 2004;22:1095-1102.
31. Grignani G, Perissinotto E, Cavalloni G et al. Clinical use of AMD3100 to mobilize CD34+ cells in patients affected by non-Hodgkin's lymphoma or multiple myeloma. J Clin Oncol 2005;23:3871-3872; comment 3872-3873.
32. Tamamura H, Fujii N. Two orthogonal approaches to overcome multidrug resistant HIV-1s: Development of protease inhibitors and entry inhibitors based on CXCR4 antagonists. Curr Drug Targets Infect Disord 2004;4:103-110.
33. Fujii N, Tamamura H. Peptide-lead CXCR4 antagonists with high anti-HIV activity. Curr Opin Investig Drugs 2001;2:1198-1202.
34. Trent JO, Wang ZX, Murray JL et al. Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists. J Biol Chem 2003;278:47136-47144.
35. Zhang WB, Navenot JM, Haribabu B et al. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J Biol Chem 2002;277:24515- 24521.
36. Maghazachi AA. G protein-coupled receptors in natural killer cells. J Leukoc Biol 2003;74:16-24.
37. Kowalska MA, Ratajczak J, Hoxie J et al. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: Determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br J Haematol 1999;104:220-229.